R. Higashiyama

发表

Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression

Y. Ohe, Midori Tanaka, N. Yamamoto, 2020, Journal of Cancer Research and Clinical Oncology.

Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients

Y. Ohe, A. Kuchiba, N. Yamamoto, 2022, Journal of Cancer Research and Clinical Oncology.

Low‐dose lamotrigine augmentation therapy improves residual symptoms in treatment‐resistant schizophrenia: A report of five cases

H. Arai, N. Shibata, T. Ohnuma, 2013, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Associations of common copy number variants in glutathione S‐transferase mu 1 and D‐dopachrome tautomerase‐like protein genes with risk of schizophrenia in a Japanese population

H. Arai, N. Shibata, T. Ohnuma, 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

A Case of Paraneoplastic Limbic Encephalitis due to Small Cell Lung Cancer in Which Treatment Led to a Recovery from Coma to a Workable Condition

A. Shiraki, R. Higashiyama, Harunori Nakashima, 2019, Haigan.

Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia

M. Ikeda, R. Hashimoto, H. Yamamori, 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.

H. Arai, N. Shibata, T. Ohnuma, 2014, Schizophrenia bulletin.

Clinical Interventions in Aging Dovepress

H. Arai, N. Shibata, T. Ota, 2022 .

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2015, Neuroscience Letters.

Medium‐chain triglycerides given in the early stage of mild‐to‐moderate Alzheimer's disease enhance memory function

H. Arai, N. Shibata, T. Ota, 2017, Psychogeriatrics.

Safety implications of switching pembrolizumab dosage from 200 mg Q3W to 400 mg Q6W in patients with advanced non-small-cell lung cancer.

Y. Ohe, N. Yamamoto, H. Horinouchi, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia.

D. Maruyama, A. Maeshima, S. Makita, 2018, Japanese journal of clinical oncology.

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia

Yusuke Suzuki, Y. Tomino, H. Arai, 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients

Y. Ohe, A. Kuchiba, N. Yamamoto, 2022, Journal of Cancer Research and Clinical Oncology.

No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease

H. Arai, N. Shibata, T. Ohnuma, 2012, Dementia and Geriatric Cognitive Disorders Extra.

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

H. Arai, N. Shibata, T. Ota, 2016, Clinical interventions in aging.

Associations of common copy number variants in glutathione S‐transferase mu 1 and D‐dopachrome tautomerase‐like protein genes with risk of schizophrenia in a Japanese population

H. Arai, N. Shibata, T. Ohnuma, 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Low‐dose lamotrigine augmentation therapy improves residual symptoms in treatment‐resistant schizophrenia: A report of five cases

H. Arai, N. Shibata, T. Ohnuma, 2013, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.